BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10554750)

  • 1. Antepartum and postpartum Papanicolaou smears. Are they both necessary?
    Jazayeri A; Heffron JA; Harnetty P; Jazayeri M; Gould SF
    J Reprod Med; 1999 Oct; 44(10):879-82. PubMed ID: 10554750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of the postpartum Papanicolaou smear.
    Rarick TL; Tchabo JG
    Obstet Gynecol; 1994 May; 83(5 Pt 1):761-5. PubMed ID: 8164940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal Papanicolaou smears after earlier smears with atypical squamous cells.
    Ridgley R; Hernandez E; Cruz C; Miyazawa K
    J Reprod Med; 1988 Mar; 33(3):285-8. PubMed ID: 3361519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of delivery route on natural history of cervical dysplasia.
    Kaneshiro BE; Acoba JD; Holzman J; Wachi K; Carney ME
    Am J Obstet Gynecol; 2005 May; 192(5):1452-4. PubMed ID: 15902135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papanicolaou smears without endocervical cells. Are they inadequate?
    Kivlahan C; Ingram E
    Acta Cytol; 1986; 30(3):258-60. PubMed ID: 3459326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The postpartum Papanicolaou smear.
    Weiss BD; Senf JH; Udall W
    J Am Board Fam Pract; 1989; 2(1):4-9. PubMed ID: 2538045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papanicolaou smear adequacy: effect of different techniques in specific fertility states.
    Hamblin JE; Brock CD; Litchfield L; Dias J
    J Fam Pract; 1985 Mar; 20(3):257-60. PubMed ID: 3973541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
    Martin-Hirsch P; Rash B; Martin A; Standaert B
    BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cytology in vulnerable pregnant women.
    Loomis DM; Pastore PA; Rejman K; Gutierrez KL; Bethea B
    J Am Acad Nurse Pract; 2009 May; 21(5):287-94. PubMed ID: 19432913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and management of abnormal pap smear in antenatal care clinic at Thammasat University Hospital.
    Sueblinvong T; Suwannarurk K; Chanthasenanont A; Treetampinich C; Pongrojpaw D
    J Med Assoc Thai; 2005 Feb; 88(2):133-7. PubMed ID: 15962660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of colposcopy in evaluating cervical intraepithelial neoplasia during pregnancy.
    Behnam K; Mariano E
    Diagn Gynecol Obstet; 1982; 4(2):133-5. PubMed ID: 7094819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pro or contra Papanicolaou cytologic smear every 3 years].
    Delaloye JF; De Grandi P
    Schweiz Med Wochenschr; 1998 Jun; 128(23):909-13. PubMed ID: 9658520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The colposcopic impression. Is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear?
    Pretorius RG; Belinson JL; Zhang WH; Burchette RJ; Elson P; Qiao YL
    J Reprod Med; 2001 Aug; 46(8):724-8. PubMed ID: 11547646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory differences in cervical cytology.
    Rutledge CM; van Wolkenten RV; Levin JS
    Fam Pract Res J; 1991 Jun; 11(2):171-7. PubMed ID: 2058409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
    J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of route of delivery on regression of abnormal cervical cytologic findings in the postpartum period.
    Ahdoot D; Van Nostrand KM; Nguyen NJ; Tewari DS; Kurasaki T; DiSaia PJ; Rose GS
    Am J Obstet Gynecol; 1998 Jun; 178(6):1116-20. PubMed ID: 9662288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus typing in HIV-positive women.
    Hameed M; Fernandes H; Skurnick J; Moore D; Kloser P; Heller D
    Infect Dis Obstet Gynecol; 2001; 9(2):89-93. PubMed ID: 11495559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Papanicolaou test in pregnancy].
    Cheng X; Bian X; Lang J; Gai M; Liu X; Zhang J; Liu M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Apr; 22(2):174-6. PubMed ID: 12903522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal and postpartum Pap smears: do we need both?
    Londo R; Bjelland T; Girod C; Glasser M
    Fam Pract Res J; 1994 Dec; 14(4):359-67. PubMed ID: 7863808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.